We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+14.09%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$79.1B
AUM Growth
+$7.99B
(+11%)
Cap. Flow
-$5.86B
Cap. Flow
% of AUM
-7.4%
Top 10 Holdings %
Top 10 Hldgs %
22.63%
Holding
2,061
New
445
Increased
504
Reduced
465
Closed
231
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sysco
SYY
|
+$273M |
| 2 |
Waste Management
WM
|
+$168M |
| 3 |
Lowe's Companies
LOW
|
+$160M |
| 4 |
PNC Financial Services
PNC
|
+$154M |
| 5 |
Unilever
UL
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$548M |
| 2 |
Apple
AAPL
|
+$372M |
| 3 |
CSX Corp
CSX
|
+$369M |
| 4 |
Infosys
INFY
|
+$238M |
| 5 |
Kimberly-Clark
KMB
|
+$235M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.16% |
| 2 | Healthcare | 14.65% |
| 3 | Financials | 13.08% |
| 4 | Industrials | 9.66% |
| 5 | Consumer Discretionary | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Simply Good Foods
SMPL
$982M
| $77K | ﹤0.01% |
+2,473
| New | +$57.5K |
|
|
ERF
1102
DELISTED
Enerplus Corporation
ERF
| $77K | ﹤0.01% |
+24,769
| New | +$60.1K |
|
|
AFMD
1103
DELISTED
Affimed
AFMD
| $76K | ﹤0.01% |
+1,309
| New | +$61.6K |
|
1104
Artisan Partners
APAM
$3.02B
| $76K | ﹤0.01% |
1,523
| – | – |
|
1105
MarineMax
HZO
$788M
| $76K | ﹤0.01% |
2,177
-469
| -18% | -$14.7K |
|
1106
Insmed
INSM
$28.6B
| $76K | ﹤0.01% |
2,310
+139
| +6% | +$5.08K |
|
1107
Mitek Systems
MITK
$835M
| $76K | ﹤0.01% |
+4,276
| New | +$59.1K |
|
1108
NETGEAR
NTGR
$635M
| $76K | ﹤0.01% |
1,873
-1,235
| -40% | -$42K |
|
1109
Douglas Dynamics
PLOW
$1.02B
| $76K | ﹤0.01% |
1,789
| – | – |
|
1110
TTEC Holdings
TTEC
$124M
| $76K | ﹤0.01% |
1,050
+142
| +16% | +$9.21K |
|
1111
Bruker
BRKR
$8.14B
| $75K | ﹤0.01% |
1,388
+1,150
| +483% | +$55.1K |
|
1112
Guardant Health
GH
$22.6B
| $75K | ﹤0.01% |
+586
| New | +$67.4K |
|
1113
Integra LifeSciences
IART
$1.34B
| $75K | ﹤0.01% |
1,157
| – | – |
|
1114
Kraft Heinz
KHC
$30B
| $75K | ﹤0.01% |
2,191
| – | – |
|
|
ZIXI
1115
DELISTED
Zix Corporation
ZIXI
| $75K | ﹤0.01% |
+8,777
| New | +$62.3K |
|
1116
Hawkins
HWKN
$2.71B
| $74K | ﹤0.01% |
2,862
-90
| -3% | -$2.29K |
|
1117
Organogenesis Holdings
ORGO
$239M
| $74K | ﹤0.01% |
9,840
+8,688
| +754% | +$41.3K |
|
|
EGRX
1118
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $74K | ﹤0.01% |
1,610
+1,487
| +1,209% | +$69.5K |
|
|
EPAY
1119
DELISTED
Bottomline Technologies Inc
EPAY
| $74K | ﹤0.01% |
+1,409
| New | +$64K |
|
1120
Apogee Enterprises
APOG
$908M
| $73K | ﹤0.01% |
2,330
-1,050
| -31% | -$28.4K |
|
1121
1-800-Flowers.com
FLWS
$258M
| $73K | ﹤0.01% |
2,810
+742
| +36% | +$18K |
|
1122
Huron Consulting
HURN
$2.42B
| $73K | ﹤0.01% |
+1,245
| New | +$56.9K |
|
|
MZTI
1123
The Marzetti Company
MZTI
$3.11B
| $73K | ﹤0.01% |
398
+355
| +826% | +$61.8K |
|
1124
Medpace
MEDP
$16.5B
| $73K | ﹤0.01% |
529
| – | – |
|
1125
MannKind Corp
MNKD
$1.32B
| $73K | ﹤0.01% |
+23,443
| New | +$61.5K |
|
Similar funds
QCM
Lazard Asset Management's Q4 2020 Portfolio in Review
As of Q4 2020, Lazard Asset Management held 2,061 positions worth $79.1B, up 11% from $71.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management withdrew a net $5.86B in Q4 2020, closing 231 positions and reducing 465 holdings. Its most notable exit was Unilever NV New York Registry Shares, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Sotera Health worth $100M.
- Lazard Asset Management's largest Q4 2020 buy was Sotera Health: 3,651,831 shares worth $100M.
- Lazard Asset Management added most to Sysco in Q4 2020, an estimated $273M increase.
- Lazard Asset Management's biggest Q4 2020 reduction was Pfizer, cutting an estimated $548M.
- Lazard Asset Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $112M.
- Lazard Asset Management's ten largest holdings make up 23% of its $79.1B portfolio in Q4 2020.
- Lazard Asset Management opened 445 new positions and closed 231 in Q4 2020.
- Lazard Asset Management's portfolio value rose 11% quarter-over-quarter to $79.1B.
Based on Lazard Asset Management's 13F filing for Q4 2020, filed 11 Feb 2021.